General Information of the Compound
| Compound ID |
CP0483559
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-Pyrrolidin-1-yl-benzo[h]chromen-4-one
Show/Hide
|
||||||||||||||||||
| Synonyms |
2-(1-Pyrrolidinyl)-4H-naphtho(1,2-b)pyran-4-one
2-(N-Pirrolidil)-4-oxo-4H-nafto(1,2-b)pirano
2-(N-Pirrolidil)-4-oxo-4H-nafto(1,2-b)pirano [Italian]
2-Pyrrolidin-1-yl-benzo[h]chromen-4-one
2-pyrrolidin-1-ylbenzo[h]chromen-4-one
4H-Naphtho(1,2-b)pyran-4-one, 2-(1-pyrrolidinyl)-
61035-04-9
AC1MIJ0D
BDBM50159631
BRN 0412624
CHEMBL179914
DTXSID00209910
K 12344
SCHEMBL3535232
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C17H15NO2
|
||||||||||||||||||
| Molecular Weight |
265.312
|
||||||||||||||||||
| Canonical SMILES |
O=c1cc(oc2c3ccccc3ccc12)N1CCCC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C17H15NO2/c19-15-11-16(18-9-3-4-10-18)20-17-13-6-2-1-5-12(13)7-8-14(15)17/h1-2,5-8,11H,3-4,9-10H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
CYNBNMZZLAYOIM-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
61035-04-9
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound